Krill Oil Inhibits Cholesterol Synthesis and Stimulated Cholesterol Excretion in Hypercholesterolemic Rats

Mar Drugs. 2022 Sep 27;20(10):609. doi: 10.3390/md20100609.

Abstract

The present study aimed to investigate the antihypercholesterolemic effects of krill oil supplementation in high-cholesterol diet-induced hypercholesterolemic rats, and the mechanisms underlying these effects. Rats were divided into five groups: normal control, control (high-cholesterol diet), krill oil 100 mg/kg b.w. (high-cholesterol diet with Krill oil 100 mg/kg b.w.), and krill oil 200 mg/kg b.w. (high-cholesterol diet with Krill oil 200 mg/kg b.w.). After 12 weeks, the rats were sacrificed to observe the effects of krill oil on cholesterol synthesis and excretion. We found that krill oil supplementation suppressed total triglycerides, total cholesterol, and LDL-cholesterol levels, as well as HMG-CoA reductase activity. It stimulated AMPK phosphorylation, LDL receptor and ACAT2 expression in the liver, and the fecal output of cholesterol. Furthermore, it decreased the levels of P-selectin, sVCAM-1, and NO, as well as aortic wall thickness, demonstrating its role in the prevention of atherosclerosis. Thus, we suggest that krill oil supplementation can reduce LDL-cholesterol levels in the blood during hypercholesterolemia by stimulating the uptake of LDL-cholesterol into tissue and cholesterol excretion, as well as inhibition of cholesterol synthesis.

Keywords: cholesterol; hypercholesterolemia; krill oil.

MeSH terms

  • AMP-Activated Protein Kinases / metabolism
  • Animals
  • Cholesterol / metabolism
  • Euphausiacea*
  • Hypercholesterolemia* / drug therapy
  • Hyperlipidemias* / metabolism
  • Liver
  • Oils / pharmacology
  • Oxidoreductases / metabolism
  • P-Selectin / metabolism
  • Rats
  • Receptors, LDL / metabolism
  • Triglycerides / metabolism

Substances

  • P-Selectin
  • AMP-Activated Protein Kinases
  • Cholesterol
  • Triglycerides
  • Receptors, LDL
  • Oils
  • Oxidoreductases